Endostar first-line + chemotherapy in advanced lung squamous carcinoma
Advanced Lung Squamous Carcinoma
Enrolment: 400 · Results not recorded
Loading the evidence…
Biologic
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Advanced Lung Squamous Carcinoma
Enrolment: 400 · Results not recorded
Nasopharyngeal Carcinoma
Enrolment: 300 · Results not recorded
Soft Tissue Sarcoma, Adult, Stage IIB
Enrolment: 52 · Results not recorded
Breast Cancer
Enrolment: 69 · Results not recorded
Small Cell Lung Cancer
Enrolment: 138 · Results not recorded
Non-small Cell Lung Cancer
Enrolment: 50 · Results not recorded
Advanced Primary Lung Adenocarcinoma
Enrolment: 20 · Results not recorded
Nasopharyngeal Carcinoma
Enrolment: 30 · Results not recorded
Nasopharyngeal Neoplasms
Enrolment: 75 · Results not recorded
T Cell Lymphoma
Enrolment: 30 · Results not recorded
Melanoma
Enrolment: 70 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Radiation-induced lung injury from a single external thoracic irradiation (6 MV X-ray, 12 Gy)
Irradiation induced interstitial oedema and a significant increase in pulmonary inflammatory cells (P < 0.05) with a time-dependent rise in TGF-beta1 mRNA and immunoreactivity. Endostar significantly attenuated the increase in inflammatory cells and the elevation of TGF-beta1 expression (P < 0.05),…
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.